Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30-75
SponsorOhio State University

About this trial

The primary objective of this study is to determine whether the effect of continuous positive airway pressure (CPAP) therapy on 24-hour mean blood pressure (BP) in patients with obstructive sleep apnea (OSA) varies between symptom phenotypes.

Eligibility criteria

Qualifiers

30 to 75 years of age

Among patients with hypertension, no change in BP medication for at least 3 months.

Willing and able to give informed consent

Willing and able to complete ambulatory blood pressure monitoring at baseline and after 6-months.

Disqualifiers

Unable to apply BP cuff (e.g. arm circumference >55 cm, prior breast cancer, structural abnormalities of the arm)

Current use of CPAP or Dental Device for OSA

Category III-IV of heart failure

Presence of Cheyne-Stokes Respiration (CSR) in PSG

Trial design

Treatments tested in this trial

  • CPAP therapy

Treatment groups

1,739 Participants
are divided into 1 treatment group

Sponsors and collaborators

Ohio State University

Lead sponsor

University of Pennsylvania

Collaborator

Chang Gung Memorial Hospital

Collaborator

University of Sydney

Collaborator

The University of Western Australia

Collaborator

Peking University

Collaborator

Ruijin Hospital

Collaborator

National University of Singapore

Collaborator

University of Iceland

Collaborator

Geisinger Health

Collaborator

Charite University, Berlin, Germany

Collaborator